Charles River Laboratories International Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $1.63B | $238.0M |
| FY2020 | — | $2.11B | $228.4M |
| FY2021 | — | $2.53B | $241.2M |
| FY2022 | — | $2.98B | $233.9M |
| FY2023 | — | $3.60B | $276.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $1.63B | $238.0M |
| FY2020 | — | $2.11B | $228.4M |
| FY2021 | — | $2.53B | $241.2M |
| FY2022 | — | $2.98B | $233.9M |
| FY2023 | — | $3.60B | $276.8M |